TrialStudy of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Trial details
- Registry ID
- NCT05671835
- Phase
- Phase 2
TVRD
Tvardi Therapeutics, Incorporated
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisNCT05671835 | Tvardi Therapeutics, Incorporated | Phase 2 | Completed | 2025-08-14Actual |
Latest recorded trial changes
Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
NCT05671835 · Tvardi Therapeutics, Incorporated
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
75 participants (planned)
+ After
100 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
25 Aug 2025
+ After
14 Aug 2025
Recruitment status changed
− Before
Active not recruiting
+ After
Completed